Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 22, 2016

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Recurrent Mycosis FungoidesRefractory Mycosis FungoidesStage I Mycosis FungoidesStage II Mycosis FungoidesStage III Mycosis Fungoides
Interventions
OTHER

Quality-of-Life Assessment

At initial visit (day 1) - for determination of a baseline quality of life, patients will be given a self-reported questionnaire called the Skindex-29. Following standard of care radiation treatments, at weeks 6 \& 12, and every 3 months thereafter, patients will complete the Skindex-29 questionnaire.

OTHER

Objective Grading of Skin Findings

At initial visit (day 1) , using mSWAT the radiation oncologist can follow the patient's treatment response by accurately grading the severity of the patient's skin findings. Following standard of care radiation treatments, at weeks 6 \& 12, and every 3 months thereafter, mSWAT will again be determined by physician. Follow-up visits will continue until patient has a change in disease.

Trial Locations (1)

37232

RECRUITING

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER